MyFinsight
Home
About
Contact
Cullinan Therapeutics, Inc. (CGEM)
For the quarter ending 2025-06-30, CGEM made $102K in revenue. -$69,953K in net income. Net profit margin of -68581.37%.
Overview
Revenue
$102K
Net Income
-$69,953K
Net Profit Margin
-68581.37%
Unit: Thousand (K) dollars
Revenue Breakdown
Unrealized gain (loss) on invest...
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
2025-06-30
Net loss
-70,055
Unrealized gain (loss) on investments
102
Comprehensive loss
-69,953
Comprehensive loss attributable to noncontrolling interests
-
Comprehensive loss attributable to cullinan
-69,953
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Income Statement
Download
Download image
Comprehensive loss
attributable to cullinan
-$69,953K
Comprehensive loss
-$69,953K
Unrealized gain (loss) on
investments
$102K
Net loss
-$70,055K
Subscribe for Financial Insights